A number of metabolites in the sweat of newborns screened positive for cystic fibrosis could provide the basis for complementary diagnostic tests to sweat chloride, according to Canadian research. As well as potentially improving the diagnosis of cystic fibrosis, the findings also suggest new therapeutic targets for the disease. Non-targeted metabolite profiling was performed on ...
Already a member?
Enter your email to keep reading.